CIBC Asset Management
IDXX icon

CIBC Asset Management’s Idexx Laboratories IDXX Stock Holding History

CIBC Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.5M Buy
38,180
+362
+1% +$232K 0.05% 243
2025
Q4 		$25.6M Buy
37,818
+8,274
+28% +$5.63M 0.06% 210
2025
Q3 		$18.9M Buy
29,544
+190
+0.6% +$115K 0.05% 213
2025
Q2 		$15.7M Buy
29,354
+2,926
+11% +$1.4M 0.05% 236
2025
Q1 		$11.1M Buy
26,428
+62
+0.2% +$26.9K 0.04% 286
2024
Q4 		$10.9M Buy
26,366
+788
+3% +$346K 0.04% 273
2024
Q3 		$12.9M Buy
25,578
+1,338
+6% +$650K 0.04% 235
2024
Q2 		$11.8M Sell
24,240
-285
-1% -$143K 0.04% 236
2024
Q1 		$13.2M Buy
24,525
+1,335
+6% +$730K 0.05% 230
2023
Q4 		$12.9M Buy
23,190
+34
+0.1% +$16K 0.05% 221
2023
Q3 		$10.1M Buy
23,156
+2,284
+11% +$1.14M 0.04% 233
2023
Q2 		$10.5M Sell
20,872
-120
-0.6% -$57.5K 0.04% 231
2023
Q1 		$10.5M Buy
20,992
+174
+0.8% +$83.3K 0.04% 231
2022
Q4 		$8.49M Sell
20,818
-37
-0.2% -$14.4K 0.04% 260
2022
Q3 		$6.79M Buy
20,855
+1,019
+5% +$374K 0.03% 283
2022
Q2 		$6.96M Buy
19,836
+2,215
+13% +$903K 0.03% 269
2022
Q1 		$9.64M Buy
17,621
+438
+3% +$230K 0.03% 248
2021
Q4 		$11.3M Buy
17,183
+1,433
+9% +$900K 0.04% 229
2021
Q3 		$9.79M Buy
15,750
+239
+2% +$161K 0.04% 235
2021
Q2 		$9.8M Buy
15,511
+429
+3% +$237K 0.04% 238
2021
Q1 		$7.38M Buy
15,082
+898
+6% +$450K 0.03% 272
2020
Q4 		$7.09M Buy
14,184
+898
+7% +$402K 0.03% 262
2020
Q3 		$5.22M Buy
13,286
+531
+4% +$196K 0.03% 277
2020
Q2 		$4.21M Buy
12,755
+238
+2% +$68.9K 0.02% 285
2020
Q1 		$3.03M Sell
12,517
-650
-5% -$170K 0.02% 303
2019
Q4 		$3.44M Buy
13,167
+571
+5% +$150K 0.02% 326
2019
Q3 		$3.42M Sell
12,596
-133
-1% -$37K 0.02% 323
2019
Q2 		$3.5M Buy
12,729
+206
+2% +$50.8K 0.02% 311
2019
Q1 		$2.8M Buy
12,523
+463
+4% +$95.6K 0.02% 346
2018
Q4 		$2.24M Buy
12,060
+152
+1% +$31.2K 0.02% 351
2018
Q3 		$2.97M Buy
11,908
+158
+1% +$38.4K 0.02% 317
2018
Q2 		$2.56M Buy
11,750
+442
+4% +$91.1K 0.02% 342
2018
Q1 		$2.16M Sell
11,308
-165
-1% -$30.5K 0.01% 379
2017
Q4 		$1.79M Buy
11,473
+510
+5% +$80.3K 0.01% 437
2017
Q3 		$1.71M Buy
10,963
+24
+0.2% +$3.79K 0.01% 437
2017
Q2 		$1.77M Buy
10,939
+316
+3% +$51.3K 0.01% 429
2017
Q1 		$1.64M Buy
10,623
+7,668
+259% +$1.06M 0.01% 446
2016
Q4 		$347K Hold
2,955
– – ﹤0.01% 752
2016
Q3 		$333K Hold
2,955
– – ﹤0.01% 760
2016
Q2 		$274K Hold
2,955
– – ﹤0.01% 784
2016
Q1 		$231K Buy
2,955
+74
+3% +$5.33K ﹤0.01% 813
2015
Q4 		$210K Hold
2,881
– – ﹤0.01% 845
2015
Q3 		$214K Buy
+2,881
New +$206K ﹤0.01% 839
2015
Q2 		– Sell
-2,946
Closed -$228K – 986
2015
Q1 		$228K Sell
2,946
-22
-0.7% -$1.71K ﹤0.01% 866
2014
Q4 		$220K Buy
+2,968
New +$208K ﹤0.01% 857
2014
Q2 		– Sell
-3,366
Closed -$204K – 857
2014
Q1 		$204K Sell
3,366
-570
-14% -$34K ﹤0.01% 938
2013
Q4 		$209K Buy
+3,936
New +$207K ﹤0.01% 857

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC Asset Management's IDXX Position: Q1 2026 in Review

CIBC Asset Management increased its Idexx Laboratories (IDXX) stake by 0.96% in Q1 2026, buying an estimated $232K and bringing the position to 38,180 shares worth $21.5M. The position accounts for 0.05% of the portfolio, ranked #243.

CIBC Asset Management first reported a position in IDXX in Q4 2013 and has held it in 47 quarters since. The position peaked at $25.6M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • CIBC Asset Management held 38,180 shares of Idexx Laboratories worth $21.5M as of Q1 2026.
  • CIBC Asset Management bought 362 Idexx Laboratories shares in Q1 2026, an estimated $232K.
  • Idexx Laboratories made up 0.05% of CIBC Asset Management's portfolio in Q1 2026, its #243 holding.
  • CIBC Asset Management first reported a position in Idexx Laboratories in Q4 2013 and has held it in 47 quarters since.
  • CIBC Asset Management's Idexx Laboratories position peaked at $25.6M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.